AP

Ayush Patel

Active Director Director DIN 10429832
DIN 10429832 First appointment Dec 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value •••• Premium profile

About Ayush Patel

Data last updated:

Ayush Patel is a Director at Cogent India Cropscience Private Limited (since 2024). The company operates in Chemicals. Cogent India Cropscience Private Limited reported revenue of ₹39.4 Lakh (FY 2025).

DIN 10429832
Primary Designation Director
Industry Chemicals
First Appointment 26 Dec 2024
Oldest Company Age 11 yrs
Largest company Cogent India Cropscience Private Limited · ₹39.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Dec 20242015₹39.4 Lakh (FY 2025)Active

Board colleagues of Ayush Patel

Directorship timeline

Open interactive timeline →
Cogent India Cropscience Private Limited
Premium access

Shareholding and investment profile for Ayush Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayush Patel

Ayush Patel currently holds 1 directorship: Cogent India Cropscience Private Limited (Director, since 26 Dec 2024, revenue ₹39.4 Lakh (FY 2025)).

Ayush Patel was first appointed on 26 Dec 2024 as Director at Cogent India Cropscience Private Limited.

The current boards of Ayush Patel's companies include Anita Patel (Cogent India Cropscience Private Limited), Mukesh Patel (Cogent India Cropscience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available